(VIANEWS) – NORSK HYDRO (NHY.OL), SALMAR (SALM.OL), WDP (WDP.BR) are the highest payout ratio stocks on this list.
We have gathered information concerning stocks with the highest payout ratio up until now. The payout ratio in itself isn’t a guarantee of good investment but it’s an indicator of whether dividends are being paid and how the company chooses to issue them.
When investigating a potential investment, the dividend payout ratio is a good statistic to know so here are a few stocks with an above 30% percent payout ratio.
1. NORSK HYDRO (NHY.OL)
1923.08% Payout Ratio
Norsk Hydro ASA engages in the power production, bauxite extraction, alumina refining, aluminium smelting, and recycling activities; and provision of extruded solutions worldwide. It operates through Hydro Bauxite & Alumina, Hydro Aluminium Metal, Hydro Metal Markets, Hydro Extrusions, and Hydro Energy segments. The Hydro Bauxite & Alumina segment engages in bauxite mining activities, production of alumina, and related commercial activities, primarily the sale of alumina. The Hydro Aluminium Metal segment is involved in the primary aluminum production casting activities. This segment principally offers extrusion ingots, foundry alloys, and sheet and standard ingots. The Metal Markets segment sells products from the company's primary metal plants; operates recyclers; and trades in physical and financial metals. The Hydro Extrusions segment offers extrusion profiles, building systems, and precision tubing products for construction, automotive and heating, and ventilation and air conditioning sectors, as well as operates recycling facilities. The Hydro Energy segment engages in the trading and wholesale business in Brazil; energy sourcing operations; and operation of power stations in Norway, as well as renewable energy production, such as wind and solar, battery materials, and green hydrogen. Norsk Hydro ASA was founded in 1905 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, NORSK HYDRO has a trailing twelve months EPS of kr0.13.
PE Ratio
NORSK HYDRO has a trailing twelve months price to earnings ratio of 444.46. Meaning, the purchaser of the share is investing kr444.46 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -1.43%.
Moving Average
NORSK HYDRO’s value is way under its 50-day moving average of kr64.23 and under its 200-day moving average of kr63.74.
Revenue Growth
Year-on-year quarterly revenue growth declined by 5%, now sitting on 189.95B for the twelve trailing months.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on May 8, 2024, the estimated forward annual dividend rate is 2.5 and the estimated forward annual dividend yield is 4.4%.
Sales Growth
NORSK HYDRO’s sales growth for the next quarter is 7.6%.
More news about NORSK HYDRO.
2. SALMAR (SALM.OL)
151.76% Payout Ratio
SalMar ASA, an aquaculture company, produces and sells farmed salmon in Asia, North America, Europe, and internationally. The company operates through Fish Farming Central Norway, Fish Farming Northern Norway, Icelandic Salmon, Sales & Industry, and SalMar Aker Ocean segments. It is involved in the broodstock, harvesting, processing, and smolt production activities. In addition, the company offers fish fillets and related products. SalMar ASA was founded in 1991 and is headquartered in Kverva, Norway.
Earnings Per Share
As for profitability, SALMAR has a trailing twelve months EPS of kr13.2.
PE Ratio
SALMAR has a trailing twelve months price to earnings ratio of 48.83. Meaning, the purchaser of the share is investing kr48.83 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.71%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 272.3% and 45.3%, respectively.
Revenue Growth
Year-on-year quarterly revenue growth declined by 3.8%, now sitting on 27.63B for the twelve trailing months.
Yearly Top and Bottom Value
SALMAR’s stock is valued at kr644.50 at 12:10 EST, way under its 52-week high of kr717.60 and way above its 52-week low of kr466.00.
Sales Growth
SALMAR’s sales growth is 0.6% for the ongoing quarter and 10.5% for the next.
More news about SALMAR.
3. WDP (WDP.BR)
115.46% Payout Ratio
WDP develops and invests in logistics property (warehouses and offices). WDP has over 7 million m² of properties in its portfolio. This international portfolio of semi-industrial and logistics buildings is spread over about 300 sites at prime logistics hubs for storage and distribution in Belgium, France, the Netherlands, Luxembourg, Germany and Romania.
Earnings Per Share
As for profitability, WDP has a trailing twelve months EPS of €0.97.
PE Ratio
WDP has a trailing twelve months price to earnings ratio of 25.57. Meaning, the purchaser of the share is investing €25.57 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.89%.
Moving Average
WDP’s value is under its 50-day moving average of €25.65 and under its 200-day moving average of €26.03.
More news about WDP.
4. SANOFI (SAN.PA)
111.9% Payout Ratio
Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers products for itching, hydration, aging, cracking, overnight, and specialty skincare needs like eczema. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301, a treatment for alpha-synucleinopathies; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Adagene Inc., for the discovery and development of antibody-based therapies. It also has collaborations with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, SANOFI has a trailing twelve months EPS of €4.3.
PE Ratio
SANOFI has a trailing twelve months price to earnings ratio of 21.15. Meaning, the purchaser of the share is investing €21.15 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.82%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 7.5%, now sitting on 47.08B for the twelve trailing months.
Yearly Top and Bottom Value
SANOFI’s stock is valued at €90.96 at 12:10 EST, way under its 52-week high of €104.32 and way above its 52-week low of €80.60.
More news about SANOFI.
5. VGP (VGP.BR)
85.94% Payout Ratio
VGP NV, together with its subsidiaries, develops, owns, and manages logistics and semi-industrial real estate, and ancillary offices. It leases its properties to tenants in the logistic sector, including storing, assembling, re-conditioning, and final treatment of the goods. The company also provides property management services; asset management services related to corporate administration, financing, business planning, reporting, budgeting, management of tax and legal affairs, controlling, etc.; project management and leasing services; and facility management services, such as maintenance, waste management, and greenery maintenance services. It operates in Germany, Spain, France, Italy, the Netherlands, Austria, Portugal, the Czech Republic, Slovakia, Hungary, Romania, Serbia, and Latvia. VGP NV was founded in 1998 and is headquartered in Antwerp, Belgium.
Earnings Per Share
As for profitability, VGP has a trailing twelve months EPS of €3.2.
PE Ratio
VGP has a trailing twelve months price to earnings ratio of 30.66. Meaning, the purchaser of the share is investing €30.66 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.95%.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on May 22, 2024, the estimated forward annual dividend rate is 2.95 and the estimated forward annual dividend yield is 3.03%.
Moving Average
VGP’s value is under its 50-day moving average of €102.00 and below its 200-day moving average of €101.54.
Yearly Top and Bottom Value
VGP’s stock is valued at €98.10 at 12:10 EST, way under its 52-week high of €114.80 and way above its 52-week low of €73.10.
More news about VGP.
6. NSI N.V. (NSI.AS)
37.11% Payout Ratio
NSI N.V. is a specialist commercial property investor and the only listed real estate investment trust (REIT) focused on well-located offices in economic growth regions in The Netherlands. The NSI team aims to maximise returns for its shareholders through pro-active management of its investment portfolio, value-add initiatives, and disciplined asset rotation. The portfolio, with a value of over one billion euros, is underpinned by a strong balance sheet, with significant capacity to fund both internal and external growth. By investing in an attractive space and a high level of services for its customers, NSI can generate sustainable and growing revenues to support an attractive level of dividends.
Earnings Per Share
As for profitability, NSI N.V. has a trailing twelve months EPS of €-2.07.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -5.73%.
Yearly Top and Bottom Value
NSI N.V.’s stock is valued at €20.10 at 12:10 EST, under its 52-week high of €20.35 and way higher than its 52-week low of €16.62.
Revenue Growth
Year-on-year quarterly revenue growth grew by 0.5%, now sitting on 85.23M for the twelve trailing months.
More news about NSI N.V..
1. 1 (1)
1% Payout Ratio
1
Earnings Per Share
As for profitability, 1 has a trailing twelve months EPS of €1.
PE Ratio
1 has a trailing twelve months price to earnings ratio of 1. Meaning, the purchaser of the share is investing €1 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1%.
Volatility
1’s last week, last month’s, and last quarter’s current intraday variation average was 1.00%, 1.00%, and 1.00%.
1’s highest amplitude of average volatility was 1.00% (last week), 1.00% (last month), and 1.00% (last quarter).
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 1% and 1%, respectively.
Revenue Growth
Year-on-year quarterly revenue growth grew by 1%, now sitting on 1 for the twelve trailing months.
More news about 1.
